{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:28:57Z","timestamp":1793777337028,"version":"4.6.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["2019\u2014ID 23151"],"award-info":[{"award-number":["2019\u2014ID 23151"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015565","name":"Consorzio Interuniversitario per le Biotecnologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AIRC\u2014grant","award":["IG 2019\u2014ID 23109"],"award-info":[{"award-number":["IG 2019\u2014ID 23109"]}]},{"DOI":"10.13039\/501100023969","name":"HTS","doi-asserted-by":"publisher","award":["IRP-StG 2023"],"award-info":[{"award-number":["IRP-StG 2023"]}],"id":[{"id":"10.13039\/501100023969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023969","name":"HTS","doi-asserted-by":"publisher","award":["24\/12 IRP"],"award-info":[{"award-number":["24\/12 IRP"]}],"id":[{"id":"10.13039\/501100023969","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Umberto Veronesi Foundation","award":["FUV #5318"],"award-info":[{"award-number":["FUV #5318"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sonic hedgehog-medulloblastoma (SHH-MB) represents a biologically diverse and clinically challenging subgroup, especially in high-risk variants characterized by metastatic dissemination. Despite progress in molecular stratification, current treatments rely on intensive multimodal regimens that are associated with substantial long-term neurotoxicity. Identifying novel oncogenic mechanisms that can be therapeutically exploited is therefore a critical priority.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We combined transcriptomic analyses of patient datasets with immunohistochemistry, RNAscope, and protein profiling to evaluate PTX3 expression in MB subgroups. Functional studies were performed in SHH-MB cell lines following PTX3 knockdown or knockout. Effects on proliferation, migration, and angiogenesis were assessed through multiple in vitro assays. In vivo relevance was tested using subcutaneous and orthotopic xenograft models. Mechanistic insights were obtained through phospho-kinase arrays, Western blotting, and GSEA. A high-throughput drug screen and combination studies with specific inhibitors and standard chemotherapy (vincristine\/cisplatin\/cyclophosphamide; VCC) were performed to assess therapeutic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results reveal that PTX3 was strongly enriched in SHH-MB subgroup, where it supported proliferation, motility, and angiogenesis. Mechanistically, PTX3 activated a TLR4-dependent IRAK1\/PI3K-Akt\/GSK-3\/\u03b2-catenin signaling cascade. Genetic downregulation or pharmacologic blockade of PTX3-TLR4 significantly reduced tumor growth and angiogenesis in vivo. Moreover, the TLR4 inhibitor TAK-242 markedly impacted SHH-MB growth in vitro, and combination therapy of TAK-242 and VCC produced additive\/synergistic effects in vitro and significantly prolonged survival in orthotopic SHH-MB-bearing mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings identify PTX3-TLR4 signaling as key oncogenic driver and a promising therapeutic \u00advulnerability in SHH-MB. Targeting this pathway enhances the efficacy of standard therapy and represents a rationale for mechanism-based combination strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag167","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:56:11Z","timestamp":1784807771000},"page":"2684-2699","source":"Crossref","is-referenced-by-count":0,"title":["A PTX3\/TLR4 axis sustains sonic hedgehog-medulloblastoma growth and defines a new therapeutic vulnerability"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9795-2638","authenticated-orcid":false,"given":"Serena","family":"Filiberti","sequence":"first","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-4937","authenticated-orcid":false,"given":"Camilla","family":"Tavani","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9771-3688","authenticated-orcid":false,"given":"Elena","family":"Somenza","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5948-6361","authenticated-orcid":false,"given":"Nicolas","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1251-8136","authenticated-orcid":false,"given":"Davide","family":"Capoferri","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-2704","authenticated-orcid":false,"given":"Chiara","family":"Romani","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia and ASST Spedali Civili di Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-9033","authenticated-orcid":false,"given":"Arianna","family":"Giacomini","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8403-0607","authenticated-orcid":false,"given":"Elisabetta","family":"Grillo","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-2495","authenticated-orcid":false,"given":"Marco","family":"Ritelli","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7752-0368","authenticated-orcid":false,"given":"Tiziana","family":"Annese","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, LUM University , Casamassima (Bari),","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4810-1201","authenticated-orcid":false,"given":"Antonio","family":"d\u2019Amati","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, LUM University , Casamassima (Bari),","place":["Italy"]},{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-4157","authenticated-orcid":false,"given":"Martina","family":"Canton","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Hematology-Oncology Department of Women\u2019s and Children\u2019s Health, University of Padova , Padova,","place":["Italy"]},{"name":"Istituto di Ricerca Pediatrica (IRP) , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3960-8561","authenticated-orcid":false,"given":"Elena","family":"Mariotto","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Hematology-Oncology Department of Women\u2019s and Children\u2019s Health, University of Padova , Padova,","place":["Italy"]},{"name":"Istituto di Ricerca Pediatrica (IRP) , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-4815","authenticated-orcid":false,"given":"Roberta","family":"Bortolozzi","sequence":"additional","affiliation":[{"name":"Istituto di Ricerca Pediatrica (IRP) , Padova,","place":["Italy"]},{"name":"Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-165X","authenticated-orcid":false,"given":"Giampietro","family":"Viola","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Hematology-Oncology Department of Women\u2019s and Children\u2019s Health, University of Padova , Padova,","place":["Italy"]},{"name":"Istituto di Ricerca Pediatrica (IRP) , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-6635","authenticated-orcid":false,"given":"Andrei","family":"Turtoi","sequence":"additional","affiliation":[{"name":"Institut de Recherche en Canc\u00e9rologie de Montpellier, Universit\u00e9 de Montpellier, INSERM , Montpellier,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5662-8978","authenticated-orcid":false,"given":"Pietro Luigi","family":"Poliani","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7139-3820","authenticated-orcid":false,"given":"Marta","family":"Turati","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia , Brescia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-7068","authenticated-orcid":false,"given":"Roberto","family":"Ronca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026110401521605600_noag167-B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"2026110401521605600_noag167-B2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrc3410","article-title":"Medulloblastomics: the end of the beginning","volume":"12","author":"Northcott","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2026110401521605600_noag167-B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","article-title":"Medulloblastoma","volume":"5","author":"Northcott","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026110401521605600_noag167-B4","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"2026110401521605600_noag167-B5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/neuonc\/noab135","article-title":"Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral \u00adheterogeneity of childhood medulloblastoma","volume":"24","author":"Riemondy","year":"2022","journal-title":"Neuro Oncol"},{"key":"2026110401521605600_noag167-B6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccell.2019.07.009","article-title":"Single-cell transcriptomics in medulloblastoma reveals tumor-initiating progenitors and oncogenic Cascades during tumorigenesis and relapse","volume":"36","author":"Zhang","year":"2019","journal-title":"Cancer Cell"},{"key":"2026110401521605600_noag167-B7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral heterogeneity within medulloblastoma subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"},{"key":"2026110401521605600_noag167-B8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/10935266211018931","article-title":"Medulloblastoma: WHO 2021 and beyond","volume":"25","author":"Cotter","year":"2022","journal-title":"Pediatr Dev Pathol"},{"key":"2026110401521605600_noag167-B9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/nop\/npw013","article-title":"Core deficits and quality of survival after childhood medulloblastoma: a review","volume":"4","author":"Chevignard","year":"2017","journal-title":"Neurooncol Pract"},{"key":"2026110401521605600_noag167-B10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","article-title":"Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort","volume":"19","author":"Waszak","year":"2018","journal-title":"Lancet Oncol"},{"key":"2026110401521605600_noag167-B11","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s13311-022-01273-0","article-title":"Medulloblastoma in the modern era: review of contemporary trials, molecular advances, and updates in management","volume":"19","author":"Lazow","year":"2022","journal-title":"Neurotherapeutics"},{"key":"2026110401521605600_noag167-B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153889","article-title":"The neurodevelopmental and molecular landscape of medulloblastoma subgroups: current targets and the potential for combined therapies","volume":"15","author":"Slika","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026110401521605600_noag167-B13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13643-020-01307-8","article-title":"Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol","volume":"9","author":"Adile","year":"2020","journal-title":"Syst Rev"},{"key":"2026110401521605600_noag167-B14","doi-asserted-by":"publisher","first-page":"1624819","DOI":"10.3389\/fneur.2025.1624819","article-title":"The predictive value of pre-treatment MRI-based radiomics and clinical characteristics for medulloblastoma recurrence in pediatric patients","volume":"16","author":"Lu","year":"2025","journal-title":"Front Neurol"},{"key":"2026110401521605600_noag167-B15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev-neuro-070815-013838","article-title":"Medulloblastoma: from molecular subgroups to molecular targeted therapies","volume":"41","author":"Wang","year":"2018","journal-title":"Annu Rev Neurosci"},{"key":"2026110401521605600_noag167-B16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1582-4934.2007.00061.x","article-title":"Role of the soluble pattern recognition receptor PTX3 in vascular biology","volume":"11","author":"Presta","year":"2007","journal-title":"J Cell Mol Med"},{"key":"2026110401521605600_noag167-B17","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jhep.2016.02.029","article-title":"The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling","volume":"64","author":"Bottazzi","year":"2016","journal-title":"J Hepatol"},{"key":"2026110401521605600_noag167-B18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbcan.2017.11.004","article-title":"Long pentraxin 3: a novel multifaceted player in cancer","volume":"1869","author":"Giacomini","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2026110401521605600_noag167-B19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cell.2015.01.004","article-title":"PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer","volume":"160","author":"Bonavita","year":"2015","journal-title":"Cell"},{"key":"2026110401521605600_noag167-B20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.4181","article-title":"Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer","volume":"230","author":"Ronca","year":"2013","journal-title":"J Pathol"},{"key":"2026110401521605600_noag167-B21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2015.07.002","article-title":"Long-pentraxin 3 derivative as a Small-Molecule FGF trap for cancer therapy","volume":"28","author":"Ronca","year":"2015","journal-title":"Cancer Cell"},{"key":"2026110401521605600_noag167-B22","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.omto.2022.02.005","article-title":"Promoting role of pentraxin-3 in esophageal squamous cell carcinoma","volume":"24","author":"Fan","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"2026110401521605600_noag167-B23","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.18632\/oncotarget.3482","article-title":"PTX3 gene activation in EGF-induced head and neck cancer cell metastasis","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"key":"2026110401521605600_noag167-B24","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.7150\/jca.58698","article-title":"Pentraxin-3 inhibits milky spots metastasis of gastric cancer by inhibiting M2 macrophage polarization","volume":"12","author":"Cui","year":"2021","journal-title":"J Cancer"},{"key":"2026110401521605600_noag167-B25","doi-asserted-by":"publisher","first-page":"29385","DOI":"10.1038\/srep29385","article-title":"Knockdown of pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells","volume":"6","author":"Ying","year":"2016","journal-title":"Sci Rep"},{"key":"2026110401521605600_noag167-B26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11060-016-2168-z","article-title":"Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo","volume":"129","author":"Tung","year":"2016","journal-title":"J Neurooncol"},{"key":"2026110401521605600_noag167-B27","doi-asserted-by":"publisher","first-page":"108818","DOI":"10.1016\/j.abb.2021.108818","article-title":"Pentraxin 3 acts as a functional effector of Akt\/NF-kappaB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer","volume":"701","author":"Li","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"2026110401521605600_noag167-B28","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.7150\/jca.25188","article-title":"Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition","volume":"9","author":"Song","year":"2018","journal-title":"J Cancer"},{"key":"2026110401521605600_noag167-B29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40164-023-00441-y","article-title":"The PTX3\/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer","volume":"12","author":"Giacomini","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"2026110401521605600_noag167-B30","doi-asserted-by":"publisher","first-page":"149724","DOI":"10.1016\/j.gene.2025.149724","article-title":"Exploring PTX3: a promising diagnostic marker and therapeutic target in neurology","volume":"969","author":"Peng","year":"2025","journal-title":"Gene"},{"key":"2026110401521605600_noag167-B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jneuroim.2013.04.009","article-title":"The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas","volume":"260","author":"Locatelli","year":"2013","journal-title":"J Neuroimmunol"},{"key":"2026110401521605600_noag167-B32","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/cns.13913","article-title":"PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma","volume":"28","author":"Zhang","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"2026110401521605600_noag167-B33","doi-asserted-by":"publisher","first-page":"149665","DOI":"10.1016\/j.bbrc.2024.149665","article-title":"PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK\/ERK signalling axis","volume":"703","author":"Wang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"2026110401521605600_noag167-B34","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1016\/j.apsb.2022.09.012","article-title":"Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-kappaB \/IL-6\/STAT3 and JNK\/PTX3 pathways","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"2026110401521605600_noag167-B35","first-page":"624","article-title":"SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3","volume":"8","author":"Liu","year":"2018","journal-title":"Am J Cancer Res"},{"key":"2026110401521605600_noag167-B36","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1080\/15548627.2023.2165757","article-title":"PRMT1 driven PTX3 regulates ferritinophagy in glioma","volume":"19","author":"Lathoria","year":"2023","journal-title":"Autophagy"},{"key":"2026110401521605600_noag167-B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091637","article-title":"Pentraxin 3: a main driver of inflammation and immune system dysfunction in the tumor microenvironment of glioblastoma","volume":"16","author":"Scuderi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026110401521605600_noag167-B38","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5602","article-title":"The dual HDAC and PI3K inhibitor, CUDC\u2011907, inhibits tumor growth and stem\u2011like properties by suppressing PTX3 in neuroblastoma","volume":"64","author":"Li","year":"2024","journal-title":"Int J Oncol"},{"key":"2026110401521605600_noag167-B39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153462","article-title":"mTORC1 promotes malignant large cell\/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma","volume":"6","author":"Conti","year":"2021","journal-title":"JCI Insight"},{"key":"2026110401521605600_noag167-B40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-023-01679-7","article-title":"Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma","volume":"11","author":"Mariotto","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"2026110401521605600_noag167-B41","doi-asserted-by":"publisher","first-page":"103663","DOI":"10.1016\/j.xpro.2025.103663","article-title":"Protocol for performing angiogenic and tumorigenic assays using the in ovo chick embryo chorioallantoic membrane model","volume":"6","author":"Chastel","year":"2025","journal-title":"STAR Protoc"},{"key":"2026110401521605600_noag167-B42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbi.2015.12.012","article-title":"Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior","volume":"53","author":"Cheng","year":"2016","journal-title":"Brain Behav Immun"},{"key":"2026110401521605600_noag167-B43","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/ar.23590","article-title":"TLR4 promotes breast cancer metastasis via Akt\/GSK3beta\/beta-Catenin pathway upon LPS stimulation","volume":"300","author":"Li","year":"2017","journal-title":"Anat Rec (Hoboken)"},{"key":"2026110401521605600_noag167-B44","doi-asserted-by":"publisher","first-page":"e63298","DOI":"10.1371\/journal.pone.0063298","article-title":"TLR4 activates the beta-catenin pathway to cause intestinal neoplasia","volume":"8","author":"Santaolalla","year":"2013","journal-title":"PLoS One"},{"key":"2026110401521605600_noag167-B45","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1038\/s41388-019-0848-9","article-title":"Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)\/NF-kappaB signaling pathway","volume":"38","author":"Rathore","year":"2019","journal-title":"Oncogene"},{"key":"2026110401521605600_noag167-B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-11-8","article-title":"Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress","volume":"11","author":"Garate","year":"2014","journal-title":"J Neuroinflammation"},{"key":"2026110401521605600_noag167-B47","doi-asserted-by":"publisher","first-page":"944","DOI":"10.18632\/oncotarget.28261","article-title":"A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling","volume":"13","author":"Matissek","year":"2022","journal-title":"Oncotarget"},{"key":"2026110401521605600_noag167-B48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1215\/S1152851703000516","article-title":"Penetration of intra-arterially administered vincristine in experimental brain tumor","volume":"6","author":"Boyle","year":"2004","journal-title":"Neuro Oncol"},{"key":"2026110401521605600_noag167-B49","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","article-title":"Medulloblastoma genotype dictates blood brain barrier phenotype","volume":"29","author":"Phoenix","year":"2016","journal-title":"Cancer Cell"},{"key":"2026110401521605600_noag167-B50","doi-asserted-by":"publisher","first-page":"114091","DOI":"10.1016\/j.yexcr.2024.114091","article-title":"TAK-242 inhibits glioblastoma invasion, migration, and proneural-mesenchymal transition by inhibiting TLR4 signaling","volume":"439","author":"Feng","year":"2024","journal-title":"Exp Cell Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag167\/69921993\/noag167.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/11\/2684\/69921993\/noag167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/11\/2684\/69921993\/noag167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:52:26Z","timestamp":1793775146000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/11\/2684\/8740996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,7,23]]},"published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag167","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,7,23]]}}}